Latest news with #RichaSingh
Malaysian Reserve
16 hours ago
- Business
- Malaysian Reserve
Artificial Intelligence (A.I.) in Life Science: New Survey of 408 Researchers Reveals Split Sentiment, Surging Adoption, and Rising Trust Barriers
ARLINGTON, Va., June 20, 2025 /PRNewswire/ — New survey data from 408 global scientists and researchers reveals a rapid increase in AI adoption—alongside mounting hesitation around trust, training, and usability. As budgets tighten and workflow efficiency becomes more critical, scientists are both accelerating the use of AI and raising red flags about its limitations. The latest findings from BioInformatics' Beyond the Bench series uncover how academic, government, and industry researchers are evaluating and integrating AI into their tasks and workflows. While 87% of professionals report using AI for work-related research tasks—a sharp increase from 75% in 2023—the survey also exposes rising concerns around data fidelity, cybersecurity risks, and the readiness of current AI solutions for complex life science environments. This snapshot of market sentiment arrives at a pivotal moment, as companies seek faster insights and operational efficiencies but face institutional barriers to confident AI implementation. Key Insights from the AI in Life Sciences Survey: AI adoption is high, but value varies: 87% of researchers report using AI in their workflows, yet only 27% of avid users say it brings high value. Top providers gaining traction: Scientists identified Microsoft, Thermo Fisher Scientific, and Google DeepMind as leading organizations in developing or deploying AI in life sciences. Efficiency drives demand: Most users cite faster processing, improved throughput, and time savings as key benefits. Training and infrastructure gaps persist: Lack of regulatory clarity, insufficient user training, and organizational readiness are major hurdles to adoption. Click here to download Perceptions of AI in Life Science Survey Data 'As life science organizations look to AI to drive productivity, these findings show that value is conditional,' said Richa Singh, VP of Market Insights at BioInformatics. 'Vendors must address usability, trust, and real-world application if they want adoption to translate into impact.' About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies keep pace with shifting customer sentiment and commercial priorities. Powered by the Science Advisory Board—BioInformatic's proprietary network of more than 55,000 qualified life science professionals—each report delivers timely, survey-based insights into the market dynamics shaping product strategy, messaging, and customer engagement. Click here to subscribe. Access & Get Involved Download the AI in Life Science Free Data Highlight – Explore how your customers perceive AI, what they need, and where adoption is stalling. Inside the Minds of Scientists: How AI is Changing Life Science Research: Access the webinar on demand & download the full slide deck for deeper insights. Join the Science Advisory Board – Participate in future surveys and shape the future of life science research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. With deep domain expertise and real-time market access, BioInformatics enables commercial teams to make better, faster, and more strategic decisions.
Yahoo
14-06-2025
- Business
- Yahoo
Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers
ARLINGTON, Va., June 13, 2025 /PRNewswire/ -- New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics' Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies have evolved from January to mid-April 2025—offering a rare pre- and post-policy view of market sentiment. While the first wave of the survey was fielded prior to the announcement of new tariff policies, the second wave offers a timely comparison as labs began adjusting to anticipated policy changes under the Trump administration and broader macroeconomic pressures, including inflation, tightened research budgets, and supply chain strain. Click here to download the Lab Budgets & Funding Survey Key Survey Findings Include: Funding confidence is declining, with only 57% of labs reporting confidence in securing 2025 funding—down from 66% in the first wave. Financial strain is hitting North American labs harder than those in Europe: 46% report new funding challenges (vs. 21% in Europe), and over half are considering personnel cuts, compared to just 28% in Europe. 42% of labs cite new concerns about securing funding through year-end, signaling heightened financial risk across the sector. Cost-saving strategies are accelerating, including resource sharing, supplier renegotiations, outsourcing, and delayed equipment purchases. These findings reflect shifting institutional priorities and underscore the growing need for timely, market-aligned planning as labs face increased constraints and financial pressure. "By fielding this survey before and after key policy announcements, we're able to offer a real-time snapshot of how labs are adjusting to economic volatility," said Richa Singh, VP, Market Insights at BioInformatics. "As tariff policies begin to reshape lab planning, companies need focused, evidence-backed insights to align their strategies. This data helps commercial teams track funding sentiment, adapt messaging, and make confident, evidence-based decisions—especially in a market where priorities can change within weeks." About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies understand how customer sentiment and commercial priorities are shifting—particularly during times of uncertainty and industry disruption. Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts, and buyer behavior. The series was launched to provide a clear, unbiased view into the evolving challenges facing researchers and decision-makers—giving commercial teams actionable guidance to align strategy, messaging, and resource planning with what matters most to their customers. Access & Get Involved: Download the Lab Budgets & Funding Survey Sign up to receive monthly Beyond the Bench reports Join the Science Advisory Board — qualify to participate in surveys, earn rewards, and shape the future of scientific research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. View original content to download multimedia: SOURCE BioInformatics Inc.
Yahoo
13-06-2025
- Business
- Yahoo
Life Science Labs Signal Shifting Strategies Amid New Economic Pressures, According to Survey of 550+ Researchers
ARLINGTON, Va., June 13, 2025 /PRNewswire/ -- New survey insights reveal a measurable shift in how life science labs are responding to global financial uncertainty, rising operational costs, and upcoming U.S. tariff policies. Based on responses from more than 550 academic and industry researchers, the latest data from BioInformatics' Beyond the Bench series captures how lab priorities, purchasing decisions, and funding strategies have evolved from January to mid-April 2025—offering a rare pre- and post-policy view of market sentiment. While the first wave of the survey was fielded prior to the announcement of new tariff policies, the second wave offers a timely comparison as labs began adjusting to anticipated policy changes under the Trump administration and broader macroeconomic pressures, including inflation, tightened research budgets, and supply chain strain. Click here to download the Lab Budgets & Funding Survey Key Survey Findings Include: Funding confidence is declining, with only 57% of labs reporting confidence in securing 2025 funding—down from 66% in the first wave. Financial strain is hitting North American labs harder than those in Europe: 46% report new funding challenges (vs. 21% in Europe), and over half are considering personnel cuts, compared to just 28% in Europe. 42% of labs cite new concerns about securing funding through year-end, signaling heightened financial risk across the sector. Cost-saving strategies are accelerating, including resource sharing, supplier renegotiations, outsourcing, and delayed equipment purchases. These findings reflect shifting institutional priorities and underscore the growing need for timely, market-aligned planning as labs face increased constraints and financial pressure. "By fielding this survey before and after key policy announcements, we're able to offer a real-time snapshot of how labs are adjusting to economic volatility," said Richa Singh, VP, Market Insights at BioInformatics. "As tariff policies begin to reshape lab planning, companies need focused, evidence-backed insights to align their strategies. This data helps commercial teams track funding sentiment, adapt messaging, and make confident, evidence-based decisions—especially in a market where priorities can change within weeks." About Beyond the Bench Beyond the Bench is a free monthly intelligence series created by BioInformatics to help life science and diagnostics companies understand how customer sentiment and commercial priorities are shifting—particularly during times of uncertainty and industry disruption. Powered by the Science Advisory Board, BioInformatics' proprietary network of over 55,000 life science professionals, each report delivers survey-based insights on market trends, strategic shifts, and buyer behavior. The series was launched to provide a clear, unbiased view into the evolving challenges facing researchers and decision-makers—giving commercial teams actionable guidance to align strategy, messaging, and resource planning with what matters most to their customers. Access & Get Involved: Download the Lab Budgets & Funding Survey Sign up to receive monthly Beyond the Bench reports Join the Science Advisory Board — qualify to participate in surveys, earn rewards, and shape the future of scientific research. About BioInformatics BioInformatics, part of the Science and Medicine Group, is a leading market research and advisory firm serving the life science and diagnostic industries. The company delivers custom and syndicated research powered by a proprietary global panel of more than 55,000 professionals. View original content to download multimedia: SOURCE BioInformatics Inc.
Yahoo
06-06-2025
- Business
- Yahoo
Job Satisfaction Under Pressure: Survey of 528 Life Science Professionals Reveals Impact of Budget Cuts, Workload Increases, and Career Uncertainty
ARLINGTON, Va., June 6, 2025 /PRNewswire/ -- BioInformatics, a Science and Medicine Group company, has released the latest edition of its free monthly Beyond the Bench report, highlighting the state of job satisfaction among scientists and life science professionals across academic and industry settings. Based on a survey of 528 life science professionals, fielded March 21–25, 2025, the survey results reveal growing concerns about job security, career prospects, and the widening effects of budgetary constraints. Key Survey Findings: While 72% of professionals report being somewhat or very satisfied in their roles, 1 in 3 have experienced a decline in job security over the past year. 71% say budget constraints have negatively impacted their job security. Common cost-saving strategies include hiring freezes (42%), reduced research funding (44%), and downsizing (29%). A majority reported increased workloads tied to financial limitations—with understaffed teams taking on more responsibility without added support. "The data show that job satisfaction is being tested by economic and institutional pressures," said Richa Singh, VP Market Insights, at BioInformatics. "Professionals are feeling the weight of underfunding and uncertainty, which not only affects morale but puts retention and long-term innovation at risk." About the ReportBeyond the Bench: Job Satisfaction is part of a free monthly intelligence series powered by BioInformatics. Drawing on the Science Advisory Board—BioInformatics proprietary network of over 55,000 highly qualified life science and diagnostic professionals—these reports deliver timely, evidence-based insights on emerging workforce trends, customer priorities, and strategic shifts across the life science and analytical instrumentation industries. Why It MattersThis edition offers a pulse check on the life science workforce—equipping commercial and HR leaders with real-time insights into employee satisfaction, concerns, and motivations. Companies can use this information to: Benchmark internal job satisfaction and turnover risk Adjust messaging and engagement strategies for academic and industry customers Build a stronger employer brand by responding to workforce sentiment Inform Custom Market Research that further tailors strategy to their audiences Access & Get Involved Download the free Beyond the Bench: Job Satisfaction report Subscribe to Beyond the Bench and get free monthly insights delivered directly to your inbox. Become a member of the Science Advisory Board - If you qualify, you'll be invited to participate in surveys, earn rewards, and help shape the future of life science research! About BioInformatics BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians. Website: View original content to download multimedia: SOURCE BioInformatics Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Hans India
27-05-2025
- Business
- Hans India
When power, privilege & loopholes are weaponised against men
In a time when the world is reckoning with accountability and equality, one former CEO is stepping forward with a powerful reminder- not all victims wear the same face, and men too can fall prey to calculated manipulation, legal harassment, and personal ruin. What began as a story of love, mentorship, and partnership has turned into a chilling saga of betrayal and exploitation. A former CEO of a multinational firm has alleged that his ex-wife, Richa Singh — a CFO in a reputed company — rose to her position by leveraging not only his networks and influence but also his direct mentorship and coaching throughout their marriage. Singh's rapid professional rise was facilitated by his strategic counsel, industry introductions, and support system — all of which were extended in good faith, as any partner would, he claimed. But post their separation, she allegedly turned the very system he helped her access against him. The ex-CEO claims that Singh, along with her mother Indu Bala Jadon, has orchestrated an elaborate and ongoing campaign of legal harassment, including over 20 false or malicious cases designed solely to drain him financially, isolate him from his children, and destroy his reputation. Despite being the sole owner of his residence, he alleges that Singh forcefully ousted him from his own home and took de facto control of the property without any legal order or agreement. In a cruel twist, she has also taken custody of the children — despite not being their biological mother — and continues to block his access to them. 'She has used the children and the courts as pawns in a cruel game,' he says. 'What's worse — she's not even their mother by birth, but she's wielding that as a tool to keep hurting me.' The ongoing barrage of litigation, from frivolous FIRs to repeated bail cancellation attempts, has led him to escape from India simply to survive. He claims to have already paid over ₹7 crore to the mother-daughter duo, but they continue their pursuit for more. Singh and Indu Bala received bail from Chandigarh HC on the FIR filed by the ex-CEO citing forgery, cheating and destruction of evidence. This was after lower courts repeatedly denied bail to the two women, and after they paid back Rs 17 lakhs to the ex-husband. Upon the ex-husband's appeal, his cases against Singh were moved out of Gurugram to Jhajjar, where allegedly Singh's employer Pernod Ricard had no influence. A high powered SIT's investigations in Jhajjar revealed Singh's involvement and charges of forgery, cheating and destruction of evidence were subsequently filed against the two women in early 2020. "This isn't just a domestic dispute. It's a playbook on how laws meant to protect are being exploited to destroy. I've been attending every hearing I'm required to be, and the only reason I'm not in India is because I cannot be harassed by fake cases out here,' he says. 'It's a warning to all men — especially senior professionals and executives — who can find themselves defenseless when legal structures are misused."
